BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38587847)

  • 1. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
    Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
    Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectory of Healthcare Contact Days for Veterans With Advanced Gastrointestinal Malignancy.
    Johnson WV; Phung QH; Patel VR; Tsai AK; Arora N; Klein MA; Westanmo AD; Blaes AH; Gupta A
    Oncologist; 2024 Feb; 29(2):e290-e293. PubMed ID: 38016182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Awareness, Palliative Care Use, and Barriers to Palliative Care in Patients Undergoing Immunotherapy or Chemo-Immunotherapy for Metastatic Lung Cancer.
    McLouth LE; Gabbard J; Levine BJ; Golden SL; Lycan TW; Petty WJ; Weaver KE
    J Palliat Med; 2023 Jun; 26(6):831-836. PubMed ID: 36912809
    [No Abstract]   [Full Text] [Related]  

  • 4. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
    Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
    Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectories of Health Care Contact Days for Patients With Stage IV Non-Small Cell Lung Cancer.
    Gupta A; Nguyen P; Kain D; Robinson AG; Kulkarni AA; Johnson DH; Presley CJ; Blaes AH; Rocque GB; Ganguli I; Booth CM; Hanna TP
    JAMA Netw Open; 2024 Apr; 7(4):e244278. PubMed ID: 38587847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
    Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
    BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Contact Days Experienced by Decedents With Advanced GI Cancer.
    Patel VR; Ramesh V; Tsai AK; Sedhom R; Westanmo AD; Blaes AH; Vogel RI; Parsons HM; Hanna TP; Ganguli I; Dusetzina SB; Rocque GB; Booth CM; Gupta A
    JCO Oncol Pract; 2023 Nov; 19(11):1031-1038. PubMed ID: 37738532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.
    Bateni SB; Nguyen P; Eskander A; Seung SJ; Mittmann N; Jalink M; Gupta A; Chan KKW; Look Hong NJ; Hanna TP
    JAMA Dermatol; 2023 Nov; 159(11):1195-1204. PubMed ID: 37672282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
    JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Contact Days Among Older Cancer Survivors.
    Gupta A; Chant ED; Mohile S; Vogel RI; Parsons HM; Blaes AH; Booth CM; Rocque GB; Dusetzina SB; Ganguli I
    JCO Oncol Pract; 2024 Mar; ():OP2300590. PubMed ID: 38452315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial.
    Mackay TM; Latenstein AEJ; Augustinus S; van der Geest LG; Bogte A; Bonsing BA; Cirkel GA; Hol L; Busch OR; den Dulk M; van Driel LMJW; Festen S; de Groot DA; de Groot JB; Groot Koerkamp B; Haj Mohammad N; Haver JT; van der Harst E; de Hingh IH; Homs MYV; Los M; Luelmo SAC; de Meijer VE; Mekenkamp L; Molenaar IQ; Patijn GA; Quispel R; Römkens TEH; van Santvoort HC; Stommel MWJ; Venneman NG; Verdonk RC; van Vilsteren FGI; de Vos-Geelen J; van Werkhoven CH; van Hooft JE; van Eijck CHJ; Wilmink JW; van Laarhoven HWM; Besselink MG;
    JAMA Surg; 2024 Apr; 159(4):429-437. PubMed ID: 38353966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consuming Patients' Days: Time Spent on Ambulatory Appointments by People With Cancer.
    Kagalwalla S; Tsai AK; George M; Waldock A; Davis S; Jewett P; Vogel RI; Ganguli I; Booth C; Dusetzina SB; Rocque GB; Blaes AH; Gupta A
    Oncologist; 2024 May; 29(5):400-406. PubMed ID: 38339991
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.